Yahoo Finance: Recordati Industria Chimica e Farmaceutica SpA (BIT:REC): What Does The Future Look Like?
After Recordati Industria Chimica e Farmaceutica SpA’s (BIT:REC) earnings announcement in June 2018, analyst forecasts seem fairly subdued, as a 6.3% rise in profits is expected in the upcoming year, ...
Recordati Industria Chimica e Farmaceutica SpA (BIT:REC): What Does The Future Look Like?
Yahoo Finance: Can Recordati Industria Chimica e Farmaceutica SpA (BIT:REC) Maintain Its Strong Returns?
Can Recordati Industria Chimica e Farmaceutica SpA (BIT:REC) Maintain Its Strong Returns?
The Globe and Mail: Kepler Capital Remains a Buy on Recordati Industria Chimica e Farmaceutica SPA (0KBS)
In a report released on April 21, Niccolo Guido Storer from Kepler Capital maintained a Buy rating on Recordati Industria Chimica e Farmaceutica SPA, with a price target of €57.50. The company’s ...
Kepler Capital Remains a Buy on Recordati Industria Chimica e Farmaceutica SPA (0KBS)
affaritaliani: Congresso di Chimica Farmaceutica a Bari, nel ricordo di Musajo e Tortorella
A Bari il 27° Congresso di Chimica Farmaceutica, dall’11 al 14 settembre 2022 all’Università degli Studi “Aldo Moro”. Dalle infezioni batteriche e virali, con particolare attenzione all’emergenza ...
Congresso di Chimica Farmaceutica a Bari, nel ricordo di Musajo e Tortorella
Recordati Industria Chimica e Farmaceutica SpA is an Italy-based group engaged in the research, development, manufacture and marketing of pharmaceuticals. It promotes a wide range of pharmaceuticals, ...
Yahoo Finance: Four reasons why the Recordati Industria Chimica E Farmaceutica Spa (BIT:REC) share price could move
Four reasons why the Recordati Industria Chimica E Farmaceutica Spa (BIT:REC) share price could move
Detailed price information for Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) from The Globe and Mail including charting and trades.